Humana is scheduled to release its second-quarter results later this month, with analysts projecting single-digit earnings ...

The general mood among these heavyweight investors is divided, with 41% leaning bullish and 58% bearish. Among these notable options, 6 are puts, totaling $210,195, and 6 are calls, amounting to ...

UnitedHealth Group Incorporated UNH continues to face challenges amid a turbulent healthcare insurance landscape. The passage ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Today, Zacks Equity Research discusses The Cigna Group CI, Humana Inc. HUM, Centene Corp. CNC and Molina Healthcare, Inc. MOH ...

In a report released yesterday, David S Macdonald from Truist Financial maintained a Hold rating on Humana (HUM – Research Report), with a price target of $280.00. The companys ...

This comprehensive analysis examines Humana’s current position, strategic initiatives, and the factors that could shape its future performance in the evolving healthcare landscape.

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook.